SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017253
Filing Date
2022-08-15
Accepted
2022-08-15 09:11:41
Documents
92
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atai-20220630.htm   iXBRL 10-Q 6263994
2 EX-31.1 atai-ex31_1.htm EX-31.1 17898
3 EX-31.2 atai-ex31_2.htm EX-31.2 20219
4 EX-32.1 atai-ex32_1.htm EX-32.1 11812
5 EX-32.2 atai-ex32_2.htm EX-32.2 11835
6 GRAPHIC img105018067_0.jpg GRAPHIC 55118
  Complete submission text file 0000950170-22-017253.txt   24966284

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atai-20220630_lab.xml EX-101.LAB 995826
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atai-20220630_cal.xml EX-101.CAL 73719
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atai-20220630_pre.xml EX-101.PRE 869484
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atai-20220630_def.xml EX-101.DEF 671756
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atai-20220630.xsd EX-101.SCH 147813
86 EXTRACTED XBRL INSTANCE DOCUMENT atai-20220630_htm.xml XML 6053023
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 221162732
SIC: 2834 Pharmaceutical Preparations